Pseudo-obstruction-inducing ACTG2R257C alters actin organization and function.

Area of Science:

• Cell Biology
• Genetics
• Gastroenterology

Background:

• The ACTG2 R257C mutation is the primary genetic cause of visceral myopathy, a severe condition.
• Little is known about the disease mechanisms or treatments for ACTG2-related disorders.

Purpose of the Study:

• To investigate how the ACTG2 R257C mutation impacts actin organization and function in visceral smooth muscle cells.
• To understand the cellular basis of visceral myopathy caused by ACTG2 mutations.

Main Methods:

• Overexpression of wild-type (ACTG2WT) and mutant (ACTG2R257C) actin gamma 2 in primary human intestinal smooth muscle cells (HISMCs).
• Quantitative analysis of actin filament formation, localization, and cell functions.
• Assessment of smooth muscle contractile gene expression.

Main Results:

• ACTG2R257C significantly reduced the number, thickness, length, and branching of ACTG2 filament bundles compared to ACTG2WT.
• Global F-actin levels and ultrastructural organization remained unchanged.
• HISMCs expressing ACTG2R257C showed increased cell spreading and migration but similar collagen gel contraction.

Conclusions:

• The ACTG2 R257C mutation specifically disrupts ACTG2 filament bundle structure within HISMCs.
• These structural changes occur without altering the overall actin cytoskeleton, suggesting a targeted effect on specific actin structures.